STADA Arzneimittel
German generics company STADA Arzneimittel has an extensive product portfolio for a wide range of therapeutic purposes including pain, women's health, cardiovascular conditions and diabetes.
With in-licensing from highly-specialized partners, the group is also increasingly expanding into the biosimilars market, and its product spectrum includes well-known branded products too.
Latest STADA Arzneimittel News & Features
Today's issue
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze